Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Non-Current Assets (2016 - 2017)

Historic Non-Current Assets for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $2.3 million.

  • Tenax Therapeutics' Non-Current Assets fell 9550.45% to $2.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $22.9 million, marking a year-over-year decrease of 8568.54%. This contributed to the annual value of $9.7 million for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Non-Current Assets is $2.3 million, which was down 9550.45% from $4.5 million recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Non-Current Assets peaked at $54.0 million during Q2 2016, and registered a low of $1.3 million during Q2 2013.
  • Its 4-year average for Non-Current Assets is $20.4 million, with a median of $6.4 million in 2017.
  • Per our database at Business Quant, Tenax Therapeutics' Non-Current Assets plummeted by 1070.67% in 2013 and then plummeted by 9550.45% in 2017.
  • Over the past 4 years, Tenax Therapeutics' Non-Current Assets (Quarter) stood at $1.3 million in 2013, then surged by 3817.14% to $52.4 million in 2015, then tumbled by 81.48% to $9.7 million in 2016, then crashed by 75.91% to $2.3 million in 2017.
  • Its Non-Current Assets stands at $2.3 million for Q3 2017, versus $4.5 million for Q2 2017 and $6.4 million for Q1 2017.